About
Products
- Mirataz^® (mirtazapine transdermal ointment)
- Zimeta^™ (dipyrone injection)
Technology
- Veterinary Recombinant Biologics
- Manufacturing Process
Pipeline
Education
- Continuing Education
- KINections
Investors
News
- Press Releases
Contact Us
- Contact Us
- Careers
Menu

Test PI PDF Embed

You are here: Home / Test PI PDF Embed

Kindred Biosciences Announces Positive Results from Pilot Field Efficacy Study of its IL-4/IL-13 SINK Molecule Being Developed for the Treatment of Atopic Dermatitis in DogsMarch 24, 2020 - 8:33 am
Kindred Biosciences Announces Mirataz® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial ResultsMarch 16, 2020 - 4:03 pm
Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:04 pm

Event: Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:05 pm
Event: Kindred Biosciences to Present at Bank of America Merrill Lynch Animal Health SummitFebruary 18, 2020 - 8:38 am
Event: Kindred Biosciences to Present at Stifel Healthcare ConferenceNovember 14, 2019 - 4:11 pm

$3.78

0.28 (8.00%)

KindredBio proudly supports
Rabies Free Africa